[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 12, Issue 6 (3-2011) ::
2011, 12(6): 569-579 Back to browse issues page
Comparison of Glucose Tolerance in Patients with Graves Disease Treated with Methimazole with Those who Have Received Radioiodine
Javad Kiani , Vahid Yousefi , Maryam Tohidi , Yadollah Mehrabi , Fereydun Azizi
Endocrine research institute , azizi@endocrine.ac.ir
Abstract:   (36587 Views)

Abstract

Introduction: One of the major concern of the administration of radioiodine is its complications. Pancras has sodium iodine symporter and may concentrate radioiodine. This study compared glucose tolerance in Graves disease patients on continuous treatment with antithyroid drugs, with those who received radioiodine. Materials and Methods: In this study, 132 patients with Graves' disease who relapsed after drug  therapy  were randomly selected on by the patient preference for long-term treatment with either methimazole or radioactive iodine. In each group, fasting blood sugar, glucose tolerance test, and lipid profiles, TSH, insulin, HOMA-IR and HOMA-B were measured. Results: The two groups showed no significant difference in age sex, BMI and BP. Median FBS and HOMA-IR in the radioactive iodine group were higher than in the methimazole group (94 mg/dl vs. 90 mg/dl, P=0.019) and 1.5(1.2-2.3) vs. 1.3(0.8-2.1, P=0.045, respectively, but after adjustment there was no difference between the two groups no significant difference was seen in HOMA-B, median two-hour blood glucose and serum insulin levels, between the two groups. Conclusion: Results indicate no relationship between radioactive iodine treatment and glucose intolerance.

Keywords: Glucose tolerance, Graves disease, Radioactive iodineGlucose tolerance, Graves disease, Radioactive iodine
Full-Text [PDF 322 kb]   (4717 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2010/06/28 | Published: 2011/03/15
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kiani J, Yousefi V, Tohidi M, Mehrabi Y, Azizi F. Comparison of Glucose Tolerance in Patients with Graves Disease Treated with Methimazole with Those who Have Received Radioiodine. Iranian Journal of Endocrinology and Metabolism 2011; 12 (6) :569-579
URL: http://ijem.sbmu.ac.ir/article-1-985-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 6 (3-2011) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645